SMTI
Income statement / Annual
Last year (2023), Sanara MedTech Inc.'s total revenue was $64.99 M,
an increase of 41.77% from the previous year.
In 2023, Sanara MedTech Inc.'s net income was -$4.30 M.
See Sanara MedTech Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$64.99 M |
$45.84 M |
$24.14 M |
$15.59 M |
$11.77 M |
$5.84 M |
$6.30 M |
$5.51 M |
$3.37 M |
$2.63 M |
| Cost of Revenue |
$7.85 M
|
$6.36 M
|
$2.31 M
|
$1.62 M
|
$1.21 M
|
$507,418.00
|
$806,038.00
|
$943,579.00
|
$891,970.00
|
$803,631.00
|
| Gross Profit |
$57.14 M
|
$39.48 M
|
$21.83 M
|
$13.97 M
|
$10.56 M
|
$5.33 M
|
$5.50 M
|
$4.56 M
|
$2.48 M
|
$1.83 M
|
| Gross Profit Ratio |
0.88
|
0.86
|
0.9
|
0.9
|
0.9
|
0.91
|
0.87
|
0.83
|
0.74
|
0.69
|
| Research and Development Expenses |
$4.13 M
|
$3.37 M
|
$558,704.00
|
$40,190.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$45.98 M
|
$28.05 M
|
$18.68 M
|
$13.07 M
|
$5.74 M
|
$5.28 M
|
$4.76 M
|
$3.39 M
|
$3.84 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$56.99 M
|
$45.98 M
|
$28.05 M
|
$18.68 M
|
$13.07 M
|
$5.74 M
|
$5.28 M
|
$4.76 M
|
$3.39 M
|
$3.84 M
|
| Other Expenses |
$225,131.00
|
$2.37 M
|
$596,975.00
|
$291,370.00
|
$119,951.00
|
-$22,078.00
|
$125.00
|
$21.00
|
$60,031.00
|
$56,446.00
|
| Operating Expenses |
$61.35 M
|
$51.71 M
|
$29.21 M
|
$18.97 M
|
$13.19 M
|
$5.82 M
|
$5.36 M
|
$4.84 M
|
$3.45 M
|
$3.89 M
|
| Cost And Expenses |
$69.20 M
|
$58.08 M
|
$31.52 M
|
$20.59 M
|
$14.40 M
|
$6.33 M
|
$6.16 M
|
$5.78 M
|
$4.34 M
|
$4.70 M
|
| Interest Income |
$0.00
|
$284,746.00
|
$711.00
|
$11,528.00
|
$105,919.00
|
$0.00
|
$0.00
|
$0.00
|
$20.00
|
$103.00
|
| Interest Expense |
$475,783.00
|
$284,746.00
|
$711.00
|
$11,528.00
|
$105,919.00
|
$86,587.00
|
$126,825.00
|
$174,493.00
|
$176,892.00
|
$293,896.00
|
| Depreciation & Amortization |
$3.68 M
|
$2.63 M
|
$771,930.00
|
$408,968.00
|
$119,951.00
|
$56,936.00
|
$80,648.00
|
$60,883.00
|
$60,031.00
|
$56,446.00
|
| EBITDA |
-$289,097.00 |
-$11.85 M |
-$7.22 M |
-$4.02 M |
-$2.61 M |
-$417,970.00 |
$538,777.00 |
-$180,372.00 |
-$1.10 M |
-$1.93 M |
| EBITDA Ratio |
-0
|
-0.22
|
-0.31
|
-0.3
|
-0.21
|
-0.07
|
0.04
|
-0.04
|
-0.27
|
-0.76
|
| Operating Income Ratio |
-0.06
|
-0.27
|
-0.31
|
-0.32
|
-0.22
|
-0.09
|
0.02
|
-0.05
|
-0.29
|
-0.78
|
| Total Other Income/Expenses Net |
-$224,749.00
|
-$1.42 M
|
-$617,638.00
|
$589,468.00
|
-$95,721.00
|
-$98,714.00
|
$210,865.00
|
-$143,614.00
|
-$375,474.00
|
-$215,648.00
|
| Income Before Tax |
-$4.44 M
|
-$13.94 M
|
-$7.99 M
|
-$4.45 M
|
-$2.84 M
|
-$600,574.00
|
$331,309.00
|
-$415,747.00
|
-$1.34 M
|
-$2.28 M
|
| Income Before Tax Ratio |
-0.07
|
-0.3
|
-0.33
|
-0.29
|
-0.24
|
-0.1
|
0.05
|
-0.08
|
-0.4
|
-0.87
|
| Income Tax Expense |
$0.00
|
-$5.84 M
|
-$688,097.00
|
-$62,355.00
|
$94,427.00
|
$12,558.00
|
-$315,356.00
|
-$30,879.00
|
$198,602.00
|
-$78,145.00
|
| Net Income |
-$4.30 M
|
-$8.09 M
|
-$7.31 M
|
-$4.38 M
|
-$2.93 M
|
-$600,574.00
|
$331,309.00
|
-$415,747.00
|
-$1.34 M
|
-$2.28 M
|
| Net Income Ratio |
-0.07
|
-0.18
|
-0.3
|
-0.28
|
-0.25
|
-0.1
|
0.05
|
-0.08
|
-0.4
|
-0.87
|
| EPS |
-0.52 |
-1.02 |
-1 |
-0.76 |
-1.37 |
-0.28 |
0.17 |
-0.38 |
-1.26 |
-2.16 |
| EPS Diluted |
-0.52 |
-1.02 |
-1 |
-0.76 |
-1.37 |
-0.28 |
0.0922 |
-0.38 |
-1.25 |
-2.16 |
| Weighted Average Shares Out |
$8.28 M
|
$7.91 M
|
$7.34 M
|
$5.73 M
|
$2.13 M
|
$2.17 M
|
$1.11 M
|
$1.09 M
|
$1.07 M
|
$1.05 M
|
| Weighted Average Shares Out Diluted |
$8.28 M
|
$7.91 M
|
$7.34 M
|
$5.73 M
|
$2.13 M
|
$2.17 M
|
$2.09 M
|
$1.10 M
|
$1.07 M
|
$1.05 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
